Randomized, double-blind, placebo-controlled trial to examine the safety, pharmacokinetics and effects of Epimedium prenylflavonoids, on bone specific alkaline phosphatase and the osteoclast adaptor protein TRAF6 in post-menopausal women

10.1016/j.phymed.2021.153680

Saved in:
Bibliographic Details
Main Authors: Yong, E.L., Cheong W.-F., Huang, Zhongwei, WIN PA PA THU, ANGELICA, AMAURY CAZENAVE GASSIOT, KOK YONG SENG, LOGAN SUSAN JANE SINCLAIR
Other Authors: BIOCHEMISTRY
Format: Article
Language:English
Published: ELSEVIER GMBH 2021
Subjects:
Online Access:https://scholarbank.nus.edu.sg/handle/10635/205952
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: National University of Singapore
Language: English
id sg-nus-scholar.10635-205952
record_format dspace
spelling sg-nus-scholar.10635-2059522024-04-16T05:35:45Z Randomized, double-blind, placebo-controlled trial to examine the safety, pharmacokinetics and effects of Epimedium prenylflavonoids, on bone specific alkaline phosphatase and the osteoclast adaptor protein TRAF6 in post-menopausal women Yong, E.L. Cheong W.-F. Huang, Zhongwei WIN PA PA THU, ANGELICA AMAURY CAZENAVE GASSIOT KOK YONG SENG LOGAN SUSAN JANE SINCLAIR BIOCHEMISTRY OBSTETRICS & GYNAECOLOGY PHARMACOLOGY Science & Technology Life Sciences & Biomedicine Plant Sciences Chemistry, Medicinal Integrative & Complementary Medicine Pharmacology & Pharmacy Epimedium Postmenopausal women Safety Pharmacokinetics Bone turnover markers TRAF6 BIOCHEMICAL MARKERS HERBA-EPIMEDII OSTEOPOROSIS FLAVONOIDS TURNOVER PROLIFERATION ADIPOGENESIS METABOLISM GUIDELINES ICARIIN 10.1016/j.phymed.2021.153680 PHYTOMEDICINE 91 2021-11-11T09:02:49Z 2021-11-11T09:02:49Z 2021-10-01 2021-11-10T00:45:20Z Article Yong, E.L., Cheong W.-F., Huang, Zhongwei, WIN PA PA THU, ANGELICA, AMAURY CAZENAVE GASSIOT, KOK YONG SENG, LOGAN SUSAN JANE SINCLAIR (2021-10-01). Randomized, double-blind, placebo-controlled trial to examine the safety, pharmacokinetics and effects of Epimedium prenylflavonoids, on bone specific alkaline phosphatase and the osteoclast adaptor protein TRAF6 in post-menopausal women. PHYTOMEDICINE 91. ScholarBank@NUS Repository. https://doi.org/10.1016/j.phymed.2021.153680 0944-7113 1618-095X https://scholarbank.nus.edu.sg/handle/10635/205952 en ELSEVIER GMBH Elements
institution National University of Singapore
building NUS Library
continent Asia
country Singapore
Singapore
content_provider NUS Library
collection ScholarBank@NUS
language English
topic Science & Technology
Life Sciences & Biomedicine
Plant Sciences
Chemistry, Medicinal
Integrative & Complementary Medicine
Pharmacology & Pharmacy
Epimedium
Postmenopausal women
Safety
Pharmacokinetics
Bone turnover markers
TRAF6
BIOCHEMICAL MARKERS
HERBA-EPIMEDII
OSTEOPOROSIS
FLAVONOIDS
TURNOVER
PROLIFERATION
ADIPOGENESIS
METABOLISM
GUIDELINES
ICARIIN
spellingShingle Science & Technology
Life Sciences & Biomedicine
Plant Sciences
Chemistry, Medicinal
Integrative & Complementary Medicine
Pharmacology & Pharmacy
Epimedium
Postmenopausal women
Safety
Pharmacokinetics
Bone turnover markers
TRAF6
BIOCHEMICAL MARKERS
HERBA-EPIMEDII
OSTEOPOROSIS
FLAVONOIDS
TURNOVER
PROLIFERATION
ADIPOGENESIS
METABOLISM
GUIDELINES
ICARIIN
Yong, E.L.
Cheong W.-F.
Huang, Zhongwei
WIN PA PA THU, ANGELICA
AMAURY CAZENAVE GASSIOT
KOK YONG SENG
LOGAN SUSAN JANE SINCLAIR
Randomized, double-blind, placebo-controlled trial to examine the safety, pharmacokinetics and effects of Epimedium prenylflavonoids, on bone specific alkaline phosphatase and the osteoclast adaptor protein TRAF6 in post-menopausal women
description 10.1016/j.phymed.2021.153680
author2 BIOCHEMISTRY
author_facet BIOCHEMISTRY
Yong, E.L.
Cheong W.-F.
Huang, Zhongwei
WIN PA PA THU, ANGELICA
AMAURY CAZENAVE GASSIOT
KOK YONG SENG
LOGAN SUSAN JANE SINCLAIR
format Article
author Yong, E.L.
Cheong W.-F.
Huang, Zhongwei
WIN PA PA THU, ANGELICA
AMAURY CAZENAVE GASSIOT
KOK YONG SENG
LOGAN SUSAN JANE SINCLAIR
author_sort Yong, E.L.
title Randomized, double-blind, placebo-controlled trial to examine the safety, pharmacokinetics and effects of Epimedium prenylflavonoids, on bone specific alkaline phosphatase and the osteoclast adaptor protein TRAF6 in post-menopausal women
title_short Randomized, double-blind, placebo-controlled trial to examine the safety, pharmacokinetics and effects of Epimedium prenylflavonoids, on bone specific alkaline phosphatase and the osteoclast adaptor protein TRAF6 in post-menopausal women
title_full Randomized, double-blind, placebo-controlled trial to examine the safety, pharmacokinetics and effects of Epimedium prenylflavonoids, on bone specific alkaline phosphatase and the osteoclast adaptor protein TRAF6 in post-menopausal women
title_fullStr Randomized, double-blind, placebo-controlled trial to examine the safety, pharmacokinetics and effects of Epimedium prenylflavonoids, on bone specific alkaline phosphatase and the osteoclast adaptor protein TRAF6 in post-menopausal women
title_full_unstemmed Randomized, double-blind, placebo-controlled trial to examine the safety, pharmacokinetics and effects of Epimedium prenylflavonoids, on bone specific alkaline phosphatase and the osteoclast adaptor protein TRAF6 in post-menopausal women
title_sort randomized, double-blind, placebo-controlled trial to examine the safety, pharmacokinetics and effects of epimedium prenylflavonoids, on bone specific alkaline phosphatase and the osteoclast adaptor protein traf6 in post-menopausal women
publisher ELSEVIER GMBH
publishDate 2021
url https://scholarbank.nus.edu.sg/handle/10635/205952
_version_ 1800915044759764992